Table 2.
Clinical and demographic characteristics of 72 patients that underwent gastric resection or gastrectomy according to application of post-CTx
| Characteristic | No adjuvant therapy (n = 20) | Adjuvant therapy (n = 52) | p-value | |||
|---|---|---|---|---|---|---|
| No. | % | No. | % | |||
| Gender | Male | 12 | 60.0 | 36 | 69.2 | 0.457 |
| Female | 8 | 40.0 | 16 | 30.8 | ||
| Age[y] | Median | 64.19 | 59.89 | 0.052 | ||
| Range | 37.13 – 78.77 | 30.63 – 83.24 | ||||
| BMI | Median | 24.9 | 25.6 | 0.817 | ||
| Range | 18.6 – 35.0 | 16.0 – 37.1 | ||||
| ASA | ||||||
| I | 0 | 0.0 | 5 | 9.8 | 0.485 | |
| II | 15 | 75.0 | 27 | 52.9 | ||
| III | 5 | 25.0 | 19 | 37.2 | ||
| Medication | ||||||
| Cortisone | yes | 0 | 0.0 | 0 | 0.0 | - |
| no | 20 | 100.0 | 52 | 100.0 | ||
| IS | yes | 0 | 0.0 | 2 | 3.8 | 0.374 |
| no | 20 | 100.0 | 50 | 96.2 | ||
| HTN | yes | 11 | 55.0 | 23 | 44.4 | 0.953 |
| no | 9 | 45.0 | 29 | 55.8 | ||
| Comorbidities | ||||||
| DM | no | 19 | 95.0 | 46 | 88.5 | |
| NIDDM | 1 | 5.0 | 6 | 11.5 | 0.402 | |
| IDDM | 0 | 0.0 | 0 | 0.0 | ||
| CHD | yes | 1 | 5.0 | 6 | 11.5 | 0.402 |
| no | 19 | 95.0 | 46 | 88.5 | ||
| Cirrhosis Child A | 0 | 0.0 | 0 | 0.0 | - | |
| no | 20 | 100 | 52 | 100.0 | ||
| COPD | yes | 0 | 0.0 | 0 | 0.0 | - |
| no | 20 | 100.0 | 52 | 100.0 | ||
| Primary tumor location | ||||||
| AEG II | 10 | 50.0 | 12 | 23.1 | ||
| AEG III | 1 | 5.0 | 7 | 13.5 | 0.222 | |
| Corpus | 6 | 30.0 | 18 | 34.6 | ||
| Pylorus | 3 | 15.0 | 14 | 26.9 | ||
| unknown | 0 | 0 | 1 | 1.9 | ||
| ypUICC-Stage | ||||||
| 0 | 1 | 5.0 | 7 | 13.5 | ||
| I | 8 | 40.0 | 17 | 32.7 | 0.733 | |
| II | 5 | 25.0 | 11 | 21.2 | ||
| III | 6 | 30.0 | 17 | 32.7 | ||
| ypT-Stage | ||||||
| 0 | 2 | 10.0 | 7 | 13.5 | ||
| 1 | 3 | 15.0 | 10 | 19.2 | 0.120 | |
| 2 | 7 | 35.0 | 12 | 23.1 | ||
| 3 | 4 | 20.0 | 21 | 40.4 | ||
| 4 | 4 | 20.0 | 2 | 3.8 | ||
| ypN-Stage | ||||||
| 0 | 12 | 60.0 | 32 | 61.5 | ||
| 1 | 6 | 30.0 | 14 | 26.9 | 0.237 | |
| 2 | 0 | 0 | 5 | 9.6 | ||
| 3 | 2 | 10.0 | 1 | 1.9 | ||
| ypM-Stage | ||||||
| 0 | 20 | 100 | 50 | 96.2 | 0.374 | |
| x | 0 | 0 | 2 | 3.8 | ||
| Histological type | ||||||
| diffuse | 5 | 25.0 | 18 | 34.6 | ||
| intestinal | 7 | 35.0 | 19 | 36.5 | 0.743 | |
| mixtype | 1 | 5.0 | 1 | 1.9 | ||
| unknown | 7 | 35.0 | 14 | 26.9 | ||
CHD coronary heart disease, AEG adenocarcinoma of the esophageal-gastric junction, HTN hypertension